SCA
DVAX

Spearhead Capital Advisors’s Dynavax Technologies DVAX Stock Holding History

Spearhead Capital Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$114K Sell
10,941
-10,032
-48% -$131K 0.12% 96
2022
Q2 		$264K Sell
20,973
-290
-1% -$3.08K 0.04% 135
2022
Q1 		$230K Buy
+21,263
New +$258K 0.03% 173

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spearhead Capital Advisors's DVAX Position: Q3 2022 in Review

Spearhead Capital Advisors reduced its Dynavax Technologies (DVAX) stake by 48% in Q3 2022, selling an estimated $131K and leaving 10,941 shares worth $114K. The position accounts for 0.12% of the portfolio, ranked #96.

Spearhead Capital Advisors first reported a position in DVAX in Q1 2022 and has held it in 3 quarters since. The position peaked at $264K in Q2 2022. 236 funds tracked by Wall St. Rank hold DVAX as of Q3 2022.

  • Spearhead Capital Advisors held 10,941 shares of Dynavax Technologies worth $114K as of Q3 2022.
  • Spearhead Capital Advisors sold 10,032 Dynavax Technologies shares in Q3 2022, an estimated $131K.
  • Dynavax Technologies made up 0.12% of Spearhead Capital Advisors's portfolio in Q3 2022, its #96 holding.
  • Spearhead Capital Advisors first reported a position in Dynavax Technologies in Q1 2022 and has held it in 3 quarters since.
  • Spearhead Capital Advisors's Dynavax Technologies position peaked at $264K in Q2 2022.
  • 236 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.